Get started
Author

Nikolaos Ioannou

Observed names: N Ioannou, N. Ioannou, NIKOLAOS IOANNOU
ORCID: 0000-0002-7956-5543
Observed ORCID: 0000-0002-7956-5543
OpenAlex ID: A5048332192
Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity
2021 · Bola S. Hanna, Laura Llaó-Cid, et al. · Immunity · 131
Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
2011 · N Ioannou, A G Dalgleish, et al. · British Journal of Cancer · 78
PDF
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy
2020 · Nikolaos Ioannou, Patrick R. Hagner, et al. · Blood · 50
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells
2013 · Nikolaos Ioannou, Alan M Seddon, et al. · BMC Cancer · 47
PDF
Immunomodulatory Drugs for the Treatment of B Cell Malignancies
2021 · Nikolaos Ioannou, Khushi Jain, et al. · International Journal of Molecular Sciences · 40
PDF
Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses
2022 · Ernesto Gargiulo, Elodie Viry, et al. · Blood Cancer Discovery · 36
PDF
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition
2016 · NIKOLAOS IOANNOU, ALAN M. SEDDON, et al. · International Journal of Oncology · 29
PDF
Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy
2021 · Benedetta Apollonio, Nikolaos Ioannou, et al. · Frontiers in Oncology · 26
PDF
T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities
2020 · Anna Vardi, Elisavet Vlachonikola, et al. · Clinical Cancer Research · 25
Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma
2021 · Charlotte Elizabeth Graham, Agnieszka Jozwik, et al. · Leukemia · 24
PDF
Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial
2023 · Despoina Papazoglou, Xin Victoria Wang, et al. · Blood · 23
PDF
Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancer
2012 · N Ioannou · Frontiers in bioscience · 21
PDF
A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice
2021 · Piers E. M. Patten, Gerardo Ferrer, et al. · Frontiers in Immunology · 18
PDF
Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia
2023 · Giulia Pagano, Iria Fernandez Botana, et al. · Haematologica · 17
Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures
2022 · Alicia M. Vaca, Nikolaos Ioannou, et al. · Leukemia · 16
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy
2023 · Francesca Arruga, Marta Rubin, et al. · Haematologica · 13
Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer
2020 · Tanzeel Khan, Alan Seddon, et al. · Oncology Reports · 12
PDF
miR-181c-BRK1 axis plays a key role in actin cytoskeleton-dependent T cell function
2018 · Shok Ping Lim, Nikolaos Ioannou, et al. · Journal of Leukocyte Biology · 10
Allogeneic Anti-CD19 CAR T Cells Manufactured from Healthy Donors Provide a Unique Cellular Product with Distinct Phenotypic Characteristics Compared to CAR T Cells Generated from Patients with Mature B Cell Malignancies
2019 · Charlotte Graham, Agnieszka Jozwik, et al. · Blood · 5
The Tigit/CD226/CD155 Immunomodulatory Axis Is Deregulated in CLL and Contributes to B-Cell Anergy
2021 · Francesca Arruga, Andrea Iannello, et al. · Blood · 3
Eliciting Anti-Tumor T Cell Immunity in Chronic Lymphocytic Leukemia (CLL) with PD-L1/PD-1 Blockade Is Enhanced By Avadomide Immunotherapy through the Triggering of Immunogenic Interferon Signaling
2018 · Nikolaos Ioannou, Patrick R. Hagner, et al. · Blood · 3
Progressive T cell defects correlate with disease outcome in high-count monoclonal B-cell lymphocytosis
2025 · Sameer A. Parikh, Nikolaos Ioannou, et al. · Leukemia · 1
Data from Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses
2023 · Ernesto Gargiulo, Elodie Viry, et al. · 1
Supplementary Table S2 from Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses
2023 · Ernesto Gargiulo, Elodie Viry, et al. · 1
S141: Eliciting Anti-tumor T Cell Activity in Chronic Lymphocytic Leukemia With Bispecific Antibody-based Combination Therapy
2022 · D. Papazoglou, L. Ysebaert, et al. · HemaSphere · 1
Works count: 62
Citation count: 632
H-index: 15
I10-index: 18
Year
Topic
Type